Launch of ADH MASTR™ v2

Launch of ADH MASTR� v2

February 17, 2015

The new ADH MASTR™ v2 molecular assay is now released for research use only. this assay is an update of the current ADH MASTR™ assay.


As was the case for the current ADHMASTR™ kit, this new assay is provided as a ready-to-use kit, for the MPS-based identification of all SNVs and CNVs in 3 genes  (LDLR, PCSK9, APOE) and part of exon 26 (c.10200 to c.11100) of APOB, underlying monogenic hypercholesterolemia.


Now, in addition, this update assay contains a fifth PCR mix with primers for 12 SNP locations, allowing to study variable penetrance or risk profiling in individuals respectively with or without a monogenic cause.
The other four PCR mixes have not changed. The assay design and workflow protocol is exactly the same as the previous ADH MASTR™, as is the compatibility with MiSeq®, Ion PGMTM and 454TM GS.
The ADH MASTR™ will be fully replaced with the ADH MASTR™ v2.

BRCA Tumor MASTR Plus Product launch

BRCA Tumor MASTR Plus Product launch

Multiplicom is pleased to announce the release of the BRCA Tumor MASTR Plus molecular assay, research use only, for identification of SNVs in the coding region of BRCA1 and BRCA2 in various types of solid tumors.

June 17, 2015 More +
Protease and phosphatase inhibitor cocktails

Protease and phosphatase inhibitor cocktails

Protease and phosphatase inhibitors are essential components of most cell lysis and protein isolation procedures. Abcam has developed a range of convenient and easy to use protease and phosphatase inhibitor cocktails, which are suitable for a variety of applications.

April 30, 2015 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us